Publications

Title

Author

Year

Modelling the social and structural determinants of tuberculosis: opportunities and challenges.

PEDRAZZOLI, D; BOCCIA, D; Dodd, PJ; Lönnroth, K; Dowdy, DW; Siroka, A; Kimerling, ME; WHITE, RG; HOUBEN, RM G J;

2017

The international journal of tuberculosis and lung disease, (2017).21 9 10.5588/ijtld.16.0906.

Tuberculosis active case finding in Cambodia: a pragmatic, cost-effectiveness comparison of three implementation models.

James, R; Khim, K; BOUDARENE, L; Yoong, J; Phalla, C; Saint, S; Koeut, P; Mao, TE; COKER, R; KHAN, MS;

2017

BMC infectious diseases, (2017).17 1 10.1186/s12879-017-2670-8.

Urinary Lipoarabinomannan Detection and Disseminated Nontuberculous Mycobacterial Disease.

GUPTA-WRIGHT, A; Kerkhoff, AD; Meintjes, G; CORBETT, EL;

2017

Clinical infectious diseases, (2017).66 1 10.1093/cid/cix735.

Delayed effects of transcriptional responses in Mycobacterium tuberculosis exposed to nitric oxide suggest other mechanisms involved in survival.

Cortes, T; Schubert, OT; Banaei-Esfahani, A; Collins, BC; Aebersold, R; Young, DB;

2017

Scientific reports, (2017).7 1 10.1038/s41598-017-08306-1.

Improving ART programme retention and viral suppression are key to maximising impact of treatment as prevention - a modelling study.

MCCREESH, N; ANDRIANAKIS, I; Nsubuga, RN; Strong, M; Vernon, I; McKinley, TJ; Oakley, JE; Goldstein, M; HAYES, R; WHITE, RG;

2017

BMC infectious diseases, (2017).17 1 10.1186/s12879-017-2664-6.

A clinical scoring system to prioritise investigation for tuberculosis among adults attending HIV clinics in South Africa.

HANIFA, Y; FIELDING, KL; Chihota, VN; Adonis, L; Charalambous, S; FOSTER, N; Karstaedt, A; McCarthy, K; Nicol, MP; Ndlovu, NT; Sinanovic, E; Sahid, F; Stevens, W; VASSALL, A; CHURCHYARD, GJ; GRANT, AD;

2017

PloS one, (2017).12 8 10.1371/journal.pone.0181519.

Single nucleotide polymorphisms in efflux pumps genes in extensively drug resistant Mycobacterium tuberculosis isolates from Pakistan.

Kanji, A; Hasan, R; Ali, A; Zaver, A; Zhang, Y; Imtiaz, K; Shi, W; CLARK, TG; MCNERNEY, R; PHELAN, J; Rao, S; Shafiq, S; Hasan, Z;

2017

Tuberculosis (Edinburgh, Scotland), (2017).107 Supple 10.1016/j.tube.2017.07.012.

Mental disorders and drug/alcohol use in patients commencing extensively drug-resistant tuberculosis treatment.

Scuffell, J; BOCCIA, D; Garcia Velarde, F; Leon, SR; Raviola, G; Lecca, L; Galea, JT;

2017

Public health action, (2017).7 3 10.5588/pha.17.0044.

Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia.

Sengstake, S; Bergval, IL; Schuitema, AR; De Beer, JL; PHELAN, J; De Zwaan, R; CLARK, TG; Van Soolingen, D; Anthony, RM;

2017

BMC infectious diseases, (2017).17 1 10.1186/s12879-017-2594-3.

Preventing emergence of drug resistant tuberculosis in Myanmar's transitioning health system.

KHAN, MS; HUTCHISON, C; COKER, RJ; Yoong, J; Hane, KM; Innes, AL; Khaing, TM; Aung, S;

2017

Health policy and planning, (2017).32 suppl_ 10.1093/heapol/czx093.